These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32657413)

  • 1. Cancer mutational signatures representation by large-scale context embedding.
    Zhang Y; Xiao Y; Yang M; Ma J
    Bioinformatics; 2020 Jul; 36(Suppl_1):i309-i316. PubMed ID: 32657413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous discovery of cancer subtypes and subtype features by molecular data integration.
    Le Van T; van Leeuwen M; Carolina Fierro A; De Maeyer D; Van den Eynden J; Verbeke L; De Raedt L; Marchal K; Nijssen S
    Bioinformatics; 2016 Sep; 32(17):i445-i454. PubMed ID: 27587661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer.
    Wojtowicz D; Sason I; Huang X; Kim YA; Leiserson MDM; Przytycka TM; Sharan R
    Genome Med; 2019 Jul; 11(1):49. PubMed ID: 31349863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling clinical and molecular covariates of mutational process activity in cancer.
    Robinson W; Sharan R; Leiserson MDM
    Bioinformatics; 2019 Jul; 35(14):i492-i500. PubMed ID: 31510643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIREVAT: finding reliable variants without artifacts in human cancer samples using etiologically relevant mutational signatures.
    Kim H; Lee AJ; Lee J; Chun H; Ju YS; Hong D
    Genome Med; 2019 Dec; 11(1):81. PubMed ID: 31847917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint reconstruction of multiple gene networks by simultaneously capturing inter-tumor and intra-tumor heterogeneity.
    Tu JJ; Ou-Yang L; Yan H; Zhang XF; Qin H
    Bioinformatics; 2020 May; 36(9):2755-2762. PubMed ID: 31971577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment.
    Díaz-Gay M; Vangara R; Barnes M; Wang X; Islam SMA; Vermes I; Duke S; Narasimman NB; Yang T; Jiang Z; Moody S; Senkin S; Brennan P; Stratton MR; Alexandrov LB
    Bioinformatics; 2023 Dec; 39(12):. PubMed ID: 38096571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.
    Gendoo DM; Ratanasirigulchai N; Schröder MS; Paré L; Parker JS; Prat A; Haibe-Kains B
    Bioinformatics; 2016 Apr; 32(7):1097-9. PubMed ID: 26607490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference.
    Matsutani T; Ueno Y; Fukunaga T; Hamada M
    Bioinformatics; 2019 Nov; 35(22):4543-4552. PubMed ID: 30993319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new correlation clustering method for cancer mutation analysis.
    Hou JP; Emad A; Puleo GJ; Ma J; Milenkovic O
    Bioinformatics; 2016 Dec; 32(24):3717-3728. PubMed ID: 27540270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the role of low-frequency mutated genes in breast cancer.
    Lusito E; Felice B; D'Ario G; Ogier A; Montani F; Di Fiore PP; Bianchi F
    Bioinformatics; 2019 Jan; 35(1):36-46. PubMed ID: 29961866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring chromatin conformation and gene co-expression through graph embedding.
    Varrone M; Nanni L; Ciriello G; Ceri S
    Bioinformatics; 2020 Dec; 36(Suppl_2):i700-i708. PubMed ID: 33381846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSSV: a novel pattern-based probabilistic approach for somatic structural variation identification.
    Chen X; Shi X; Hilakivi-Clarke L; Shajahan-Haq AN; Clarke R; Xuan J
    Bioinformatics; 2017 Jan; 33(2):177-183. PubMed ID: 27659451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations.
    Liu S; Liu J; Xie Y; Zhai T; Hinderer EW; Stromberg AJ; Vanderford NL; Kolesar JM; Moseley HNB; Chen L; Liu C; Wang C
    Bioinformatics; 2021 Jun; 37(9):1189-1197. PubMed ID: 33165532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining clustered somatic mutations with SigProfilerClusters.
    Bergstrom EN; Kundu M; Tbeileh N; Alexandrov LB
    Bioinformatics; 2022 Jun; 38(13):3470-3473. PubMed ID: 35595234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutalisk: a web-based somatic MUTation AnaLyIS toolKit for genomic, transcriptional and epigenomic signatures.
    Lee J; Lee AJ; Lee JK; Park J; Kwon Y; Park S; Chun H; Ju YS; Hong D
    Nucleic Acids Res; 2018 Jul; 46(W1):W102-W108. PubMed ID: 29790943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEXCOwalk: mutual exclusion and coverage based random walk to identify cancer modules.
    Ahmed R; Baali I; Erten C; Hoxha E; Kazan H
    Bioinformatics; 2020 Feb; 36(3):872-879. PubMed ID: 31432076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SomaticSiMu: a mutational signature simulator.
    Chen D; Randhawa GS; Soltysiak MPM; de Souza CPE; Kari L; Singh SM; Hill KA
    Bioinformatics; 2022 Apr; 38(9):2619-2620. PubMed ID: 35258549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detecting presence of mutational signatures in cancer with confidence.
    Huang X; Wojtowicz D; Przytycka TM
    Bioinformatics; 2018 Jan; 34(2):330-337. PubMed ID: 29028923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUSE-XAE: MUtational Signature Extraction with eXplainable AutoEncoder enhances tumour types classification.
    Pancotti C; Rollo C; Codicè F; Birolo G; Fariselli P; Sanavia T
    Bioinformatics; 2024 May; 40(5):. PubMed ID: 38754097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.